New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:38 EDTBIIBBiogen price target raised to $377 from $293 at Brean Capital
Brean Capital raised its price target on Biogen following Q4 results. The firm cited expansion of Tecfidera into the EU, the launch of Plegridy in the US, and upcoming clinical and regulatory milestones in 2014. Shares are Buy rated.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:58 EDTBIIBDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use